Supply Chain entity
All 1 tracked stories fall under one category: disruptions. Of the tracked stories, 1 of 1 also mention Foundation Consumer Healthcare, the most common co-covered peer. We currently track 1 Supply Chain story that mention Clear Eyes Maximum Itchy Eye Relief, all published on August 24, 2026.
Last mentioned: 12h ago
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: disruptions. Of the tracked stories, 1 of 1 also mention Foundation Consumer Healthcare, the most common co-covered peer. We currently track 1 Supply Chain story that mention Clear Eyes Maximum Itchy Eye Relief, all published on August 24, 2026. Each carries 2 original sources on average.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 8 Supply Chain stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Clear Eyes Maximum Itchy Eye Relief. Shared-story counts are live from our verified record — not editorial picks.
Recall ongoing
Reports confirm the recall is continuing as of August 24; Prestige spokesperson Phil Terpolilli reiterates consumer safety priority.
FDA Class II classification reported
An FDA enforcement report classifies the recall as Class II, indicating remote probability of serious adverse health consequences.
Voluntary recall initiated
Prestige begins a voluntary recall of 39,060 bottles of Clear Eyes Maximum Itchy Eye Relief, lot 2552A, due to lack of assurance of sterility.
Prestige completes $1.05B acquisition
Prestige Consumer Healthcare acquires the Breathe Right brand and other assets from Foundation Consumer Healthcare for approximately $1.05 billion.
Prestige Consumer Healthcare's voluntary recall of 39,060 bottles of Clear Eyes Maximum Itchy Eye Relief, distributed by Medtech Products, highlights a sterility assurance breakdown in the ophthalmic supply chain. The Class II recall began July 29, covers lot 2552A expiring Sept. 30, 2027, and requires reverse logistics and traceability across retail channels.
Source: hawaiitribune-herald.com · fox32chicago.com
Clear Eyes Maximum Itchy Eye Relief is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
